Article Text
Abstract
Psoriasis vulgaris is a common skin disorder characterised by focal formation of inflamed, raised plaques that constantly shed scales derived from excessive growth of skin epithelial cells. The disease is defined by a series of linked cellular changes in the skin: hyperplasia of epidermal keratinocytes, vascular hyperplasia and ectasia, and infiltration of T lymphocytes, neutrophils, and other types of leucocyte in affected skin. In a relatively short period, psoriasis vulgaris has been conceptualised as a T lymphocyte mediated autoimmune disease and new biological therapies that target T cells have just entered routine clinical practice. Similarly, rapid progress has been made towards dissecting cellular and molecular pathways of inflammation that contribute to disease pathogenesis. This short review presents current pathogenic concepts that have emerged from genetic, genomic, and cellular information obtained in basic studies and from clinical studies of selective immune targeting drugs.
- CLA, cutaneous lymphocyte antigen
- iDC, immature dendritic cell
- IFN, interferon
- IL, interleukin
- LFA-1, leucocyte function associated antigen-1
- mDC, mature dendritic cell
- MHC, major histocompatibility complex
- NFκB, nuclear factor κB
- NK-T, natural killer T (cells)
- pDC, plasmacytoid dendritic cell
- PsA, psoriatic arthritis
- RA, rheumatoid arthritis
- STAT, signal transducer and activator of transcription
- TNF, tumour necrosis factor
- TCR, T cell receptor
- TOR, target of rapamycin
- PSORS2
- T cells
- dendsitic cells
- gene expression or genomics
- psoriasis genes or genetics
Statistics from Altmetric.com
- CLA, cutaneous lymphocyte antigen
- iDC, immature dendritic cell
- IFN, interferon
- IL, interleukin
- LFA-1, leucocyte function associated antigen-1
- mDC, mature dendritic cell
- MHC, major histocompatibility complex
- NFκB, nuclear factor κB
- NK-T, natural killer T (cells)
- pDC, plasmacytoid dendritic cell
- PsA, psoriatic arthritis
- RA, rheumatoid arthritis
- STAT, signal transducer and activator of transcription
- TNF, tumour necrosis factor
- TCR, T cell receptor
- TOR, target of rapamycin